Cargando…

Differentiation therapy: targeting breast cancer stem cells to reduce resistance to radiotherapy and chemotherapy

Detalles Bibliográficos
Autores principales:	Roy, R, Willan, PM, Clarke, R, Farnie, G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875561/ http://dx.doi.org/10.1186/bcr2496

Ejemplares similares

Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status
por: Farnie, Gillian, et al.
Publicado: (2013)

Regulation of human breast stem cells
por: Clarke, RB
Publicado: (2006)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Radiotherapy in early stage invasive breast cancer: current tendencies
por: Diaz-Gonzalez, JA, et al.
Publicado: (2005)

Targeting the right chemotherapy for the right patient
por: Conte, PF, et al.
Publicado: (2005)

The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
por: Aloia, Andrea, et al.
Publicado: (2015)

Primary chemotherapy for operable breast cancer: the NSABP experience
por: Bear, HD
Publicado: (2005)

Adjuvant chemotherapy for operable breast cancer: old vs new schema
por: Valagussa, P, et al.
Publicado: (2005)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

OA10.02. Yoga for women with breast cancer undergoing radiotherapy (XRT): a randomized clinical trial with an active stretching control group
por: Cohen, L, et al.
Publicado: (2012)

Stem cells in human breast development and cancer
por: Wicha, M, et al.
Publicado: (2005)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

Role of translational studies in optimizing palliative chemotherapy
por: Kramer, R
Publicado: (2005)

Regulation of human mammary stem cells
por: Clarke, RB, et al.
Publicado: (2003)

Other new radiotherapy techniques
por: Formenti, SC
Publicado: (2009)

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
por: Funes, H Cortés, et al.
Publicado: (2005)

Functional characterization of mammary stem cells in development and breast cancer
por: Rosen, JM, et al.
Publicado: (2003)

Apoptotic chemotherapies
por: Pardee, AB, et al.
Publicado: (2005)

Reducing surgical site infections (SSI) in breast surgeries, including a newly identified risk for sentinel node biopsies
por: Catlin, M, et al.
Publicado: (2015)

Prognostic studies in patients with high-risk primary breast cancer (HRPBC) receiving high-dose chemotherapy (HDC)
por: Nieto, Y
Publicado: (2005)

Aberrant activation of Notch signalling in human breast cancer
por: Stylianou, S, et al.
Publicado: (2006)

Growth regulation and steroid hormone resistance in breast cancer
por: Horwitz, KB
Publicado: (2000)

Insulin resistance in breast cancer: relevance and clinical implications
por: Goodwin, PJ
Publicado: (2011)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

The EGF receptor family as targets for breast cancer therapy
por: Baselga, J
Publicado: (2000)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Targeting HER2 in breast cancer: beyond trastuzumab
por: Winer, EP
Publicado: (2011)

Targeting the cell cycle for prognosis and therapy of breast cancer
por: Keyomarsi, K, et al.
Publicado: (2005)

cGMP modulates stem cells differentiation to neurons in brain in vivo pathological implications
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2011)

Molecular mechanisms of resistance to HER2-targeted therapy
por: Esteva, FJ
Publicado: (2009)

Tumour-selective transcriptional targeting for breast cancer gene therapy
por: Hurst, HC
Publicado: (2000)

Size distribution of screen-detected and interval cancers according to breast density suggests reduced screening benefit for women with higher density breasts
por: Nickson, C, et al.
Publicado: (2004)

Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014)

Using positive deviance (PD) to reduce antibiotic resistant organisms: the Canadian PD project
por: Reason, P, et al.
Publicado: (2011)

A targeted methicillin-resistant Staphylococcus aureus (MRSA) control program did not affect total nosocomial Staphylococcus aureus (SA) bloodstream infections (BSI) despite reducing MRSA BSI
por: Amri, B, et al.
Publicado: (2011)

Rapamycin reduces primary effusion lymphoma progression by targeting VEGF production and VEGF responses
por: Gasperini, P, et al.
Publicado: (2009)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Vaccine targeting HIF1A in triple negative breast cancer
por: Cecil, Denise, et al.
Publicado: (2014)

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
por: Rodenhuis, S, et al.
Publicado: (2005)

Classical versus new prognostic factors for adjuvant treatment selection based on line software to estimate risk and benefit
por: Ravdin, PM
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_n1t2a8nnihnvsd1vff8l4aj3nv